MIRADOR360 Trademark

Trademark Overview

On Monday, March 4, 2024, a trademark application was filed for MIRADOR360 with the United States Patent and Trademark Office. The USPTO has given the MIRADOR360 trademark a serial number of 98432116. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, September 18, 2024. This trademark is owned by Mirador Therapeutics, Inc.. The MIRADOR360 trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business research and data analysis in the field of pharmaceutical drug development and/or diagnostics development, namely, selecting and analyzing patient data and genetic information to assist with predicting, measuring, or evaluating the performance of pharmaceuticals in the field of pharmaceutical drug development and diagnostics development (including companion diagnostics development and complementary diagnostics development)
mirador360

General Information

Serial Number98432116
Word MarkMIRADOR360
Filing DateMonday, March 4, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateWednesday, September 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkMIRADOR THREE SIXTY
Pseudo MarkMIRADOR THREE SIX ZERO
Pseudo MarkMIRADOR THREE HUNDRED SIXTY
Goods and ServicesBusiness research and data analysis in the field of pharmaceutical drug development and/or diagnostics development, namely, selecting and analyzing patient data and genetic information to assist with predicting, measuring, or evaluating the performance of pharmaceuticals in the field of pharmaceutical drug development and diagnostics development (including companion diagnostics development and complementary diagnostics development)

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, March 4, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMirador Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, March 4, 2024NEW APPLICATION ENTERED
Monday, July 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 18, 2024ASSIGNED TO EXAMINER

Related Keywords

mirador development diagnostics drug field pharmaceutical data evaluating measuring predicting performance